According to the Zhitong Finance App, Jinhai Medical Technology (02225.HK) announced interim results for the six months ended June 30, 2026. The group's revenue was SGD 34,021 million, an increase of 134.16%; shareholders' losses amounted to SGD 4.362 million, a year-on-year decrease of 57.46%; and a loss of 0.08 Singapore points per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.